Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment

KA Kirou, M DallEra, C Aranow, HJ Anders - Frontiers in Immunology, 2022 - frontiersin.org
Treatment of systemic lupus erythematosus (SLE) currently employs agents with relatively
unselective immunosuppressive properties. However, two target-specific biological drugs …

Relationship between blood clots and COVID-19 vaccines: A literature review

SMH Atyabi, F Rommasi, MH Ramezani… - Open Life …, 2022 - degruyter.com
SARS-CoV-2 pandemic is one of the most critical pandemics during human civilization.
Several therapeutic strategies for COVID-19 management have been offered; nonetheless …

Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features

F Rommasi, MJ Nasiri, M Mirsaeidi - Molecular and cellular biochemistry, 2022 - Springer
The novel coronavirus pandemic has emerged as one of the significant medical-health
challenges of the current century. The World Health Organization has named this new virus …

Spectral-domain OCT measurements in obesity: A systematic review and meta-analysis

MA Salehi, A Karimi, S Mohammadi, JF Arevalo - PloS one, 2022 - journals.plos.org
Background Previous studies proposed possible applications of spectral-domain optical
coherence tomography (SD-OCT) measurements in prognosticating pathologies observed …

[HTML][HTML] Effectiveness of fortified garlic extract oral capsules as adjuvant therapy in hospitalized patients with coronavirus disease 2019: a triple-blind randomized …

MR Taghavi, TT Tamanaei, MB Oghazian… - Current Therapeutic …, 2023 - Elsevier
Background Herbal medicines have been extensively used to treat coronavirus disease
2019 (COVID-19). Garlic, known to exert antiviral and anti-inflammatory effects, can be …

[HTML][HTML] A review of the potential roles of antioxidant and anti-inflammatory pharmacological approaches for the management of mild-to-moderate symptomatic COVID …

S Fazio, F Affuso, P Bellavite - Medical science monitor …, 2022 - ncbi.nlm.nih.gov
In the past 2 years, the coronavirus disease 2019 (COVID-19) pandemic has driven
investigational studies and controlled clinical trials on antiviral treatments and vaccines that …

Alliaceae-Derived Supplementation Improves the Severity of COVID-19 Symptoms among Elderly Nursing Home Residents

A Vázquez-Blanquiño, L Pérez-Rodríguez… - Foods, 2024 - pmc.ncbi.nlm.nih.gov
This study investigates the effect of daily consumption of a concentrated garlic and onion
extract on COVID-19 symptoms among elderly nursing home residents. Volunteers …

Effect of Tenofovir Alafenamide Fumarate on the outcomes of hospitalized COVID-19 patients: a prospective, block-balanced, open-label, randomized controlled trial

N Yazdan Pouri, Z Shokati Eshkiki, A Talebi… - BMC Pharmacology and …, 2024 - Springer
Background The global effort to cure COVID-19 is still ongoing. Thus, a prospective, block-
balanced, open-label, randomized controlled trial was conducted to evaluate how Tenofovir …

PHARMACOLOGICAL APPROACHES TO SARS-CoV-2 INFECTION: FROM DRUG REPOSITIONING FOR COVID-19 TREATMENT TO DISEASE ARREST …

A Bergamo, A Bitto, A Grolla, G Nocentini, S Pierno… - Pharmadvances, 2022 - arts.units.it
COVID-19 disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) is one of the major emergencies that have affected health care systems and society in …

[PDF][PDF] Current knowledge on the treatment of COVID-19

M Pal, KP Gutama - MOJ Biol Med, 2022 - academia.edu
COVID-19 is a novel infectious disease that has spread over the world, causing severe
morbidity and mortality. Coronavirus-2 (SARS-CoV-2) causes this severe acute respiratory …